EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines.
Sign Up to like & getrecommendations! Published in 2023 at "Anti-cancer drugs"
DOI: 10.1097/cad.0000000000001494
Abstract: Epidermal growth factor receptor (EGFR) is one of therapeutic targets in oncology for solid tumors originating from epithelial tissue, such as non-small-cell lung carcinoma (NSCLC) and breast cancer. EGFR inhibitors used in cancer treatment may… read more here.
Keywords: egfr inhibitor; inhibitor induced; induced folliculitis; folliculitis decalvans ... See more keywords